Nanoconjugates Based on Cisplatin and Single-Walled Carbon Nanotubes for Therapy of Triple Negative Breast Cancer †
Abstract
:Supplementary Materials
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Badea, M.A.; Balas, M.; Cojocaru, F.G.; Ionita, D.; Dinischiotu, A. Nanoconjugates Based on Cisplatin and Single-Walled Carbon Nanotubes for Therapy of Triple Negative Breast Cancer. Mater. Proc. 2021, 4, 32. https://doi.org/10.3390/IOCN2020-07989
Badea MA, Balas M, Cojocaru FG, Ionita D, Dinischiotu A. Nanoconjugates Based on Cisplatin and Single-Walled Carbon Nanotubes for Therapy of Triple Negative Breast Cancer. Materials Proceedings. 2021; 4(1):32. https://doi.org/10.3390/IOCN2020-07989
Chicago/Turabian StyleBadea, Madalina Andreea, Mihaela Balas, Florentina Gina Cojocaru, Daniela Ionita, and Anca Dinischiotu. 2021. "Nanoconjugates Based on Cisplatin and Single-Walled Carbon Nanotubes for Therapy of Triple Negative Breast Cancer" Materials Proceedings 4, no. 1: 32. https://doi.org/10.3390/IOCN2020-07989
APA StyleBadea, M. A., Balas, M., Cojocaru, F. G., Ionita, D., & Dinischiotu, A. (2021). Nanoconjugates Based on Cisplatin and Single-Walled Carbon Nanotubes for Therapy of Triple Negative Breast Cancer. Materials Proceedings, 4(1), 32. https://doi.org/10.3390/IOCN2020-07989